Rice Hall James & Associates LLC grew its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD – Free Report) by 24.3% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 83,338 shares of the medical instruments supplier’s stock after buying an additional 16,297 shares during the period. Rice Hall James & Associates LLC’s holdings in Utah Medical Products were worth $5,576,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in the company. BNP Paribas Financial Markets raised its holdings in shares of Utah Medical Products by 123.0% in the 1st quarter. BNP Paribas Financial Markets now owns 8,399 shares of the medical instruments supplier’s stock worth $597,000 after purchasing an additional 4,633 shares during the period. Isthmus Partners LLC raised its holdings in Utah Medical Products by 56.8% in the first quarter. Isthmus Partners LLC now owns 35,602 shares of the medical instruments supplier’s stock valued at $2,532,000 after buying an additional 12,903 shares during the period. Vanguard Group Inc. lifted its position in Utah Medical Products by 7.3% during the first quarter. Vanguard Group Inc. now owns 183,141 shares of the medical instruments supplier’s stock valued at $13,023,000 after buying an additional 12,402 shares in the last quarter. EntryPoint Capital LLC grew its stake in Utah Medical Products by 124.1% during the first quarter. EntryPoint Capital LLC now owns 3,240 shares of the medical instruments supplier’s stock worth $230,000 after buying an additional 1,794 shares during the period. Finally, Quadrature Capital Ltd increased its position in shares of Utah Medical Products by 177.6% in the first quarter. Quadrature Capital Ltd now owns 32,310 shares of the medical instruments supplier’s stock worth $2,294,000 after acquiring an additional 20,671 shares in the last quarter. 69.60% of the stock is owned by hedge funds and other institutional investors.
Utah Medical Products Stock Performance
UTMD stock opened at $63.38 on Friday. The firm has a market cap of $220.56 million, a P/E ratio of 14.84 and a beta of 0.08. Utah Medical Products, Inc. has a 1 year low of $63.38 and a 1 year high of $87.86. The stock has a 50-day simple moving average of $66.26 and a 200-day simple moving average of $67.40.
Analyst Ratings Changes
View Our Latest Analysis on UTMD
Utah Medical Products Profile
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
See Also
- Five stocks we like better than Utah Medical Products
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 3 Stocks Well Below 52-Week Highs With Strong Growth Projections
- Stock Market Upgrades: What Are They?
- 3 Chip Stocks Expected to See Accelerating Sales Growth
- How to Calculate Stock Profit
- Super Micro Computer: Where Does it Go From Here?
Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD – Free Report).
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.